Recent insider trading activity from Hough David W., including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 12, 2024 | Kuvatris Therapeutics, Inc. | $PXMD | Hough David W. | Chief Medical Officer | F | Common Stock | 1452 | $0.69 | 5,905.0000 | 1,662,795 | 19.74% | 0.09% |
| Feb. 21, 2024 | Kuvatris Therapeutics, Inc. | $PXMD | Hough David W. | Chief Medical Officer | F | Common Stock | 291 | $0.66 | 7,357.0000 | 1,662,795 | 3.80% | 0.02% |